The paraoxonase glutamine/arginine polymorphism and cerebrovascular disease

Cerebrovascular Diseases

Volumn 7, Issue 6, 1997, Pages 353-355

  Lansbury, Alastair J ^a   Catto, Andrew J ^a   Carter, Angela M ^a   Bamford, John M ^b   Grant, Peter J ^a  

^a UNIVERSITY OF LEEDS   (United Kingdom)

^b ST JAMES S UNIVERSITY HOSPITAL   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

ARGININE; ARYLESTERASE; GLUTAMINE;

ADULT; AGED; ARTICLE; CEREBROVASCULAR DISEASE; CONTROLLED STUDY; ENZYME POLYMORPHISM; FEMALE; HUMAN; MAJOR CLINICAL STUDY; MALE; NORMAL HUMAN; PRIORITY JOURNAL;

EID: 0030779575     PISSN: 10159770     EISSN: 14219786     Source Type: Journal    
DOI: 10.1159/000108222     Document Type: Article

References (14)

1. Erdos EG, Boggs LE: Hydrolysis of paraoxon in mammalian blood. Nature 1961:190:716-717.
2. Aldrige WN: Two types of esterase (A and B) hydrolysing p-nitrophenol acetate, propionate and butyrate and a method for their determination. Biochemistry 1953;53:110-117.
3. Playfcr JR, Eze LC, Bullcn ME, Evans DA: Genetic polymorphism and interethnic variability of plasma paraoxonase activity. J Med Genet 1976; 13:337-342.
4. Adkins S, Gan KN, Modv M, La Du BN: Molecular basis for the polymorphic forms of human serum paraoxonasc/arylcsterasc: Glutamine or arginine at position 191, for the respective A or B allozymcs. Am J Hum Genet 1993;52:598-608.
5. Humbert R, Adler DA, Distcchc CM, Hassctt C, Omiecinski CJ, Furlong CE: The molecular basis of the human paraoxonase activity polymorphism. Nat Genet 1993;3:73-76.
6. McElveen J, Mackness MI, Colley CM, Pcard T, Warner S, Walker CH: Distribution of paraoxon hydrolytic activity in the scrum of patients after myocardial infarction. Clin Chem 1986;32:671-673.
7. Mackness MI, Harty D, Bhatnagar D, Winocour PH, Arrol S, Ishola M, Durrington PN: Serum paraoxonase activity in familial hypercholestcrol-aemia and insulin-dependent diabetes mcllitus. Atherosclerosis 1991:86: 193-199.
8. Serrato M, Marian AJ: A variant of human paraoxonasc/arylcsterase (HUMPONA)genc is a risk factor for coronarv arterv disease. J Clin Invest 1995;96:3005-3008.
9. Ruiz J, Blanche H, James RW, Garin MB, Vaissc C, Charpenticr G, Cohen N. Morabia A, Passa P, Frogucl P: Gln-Arg 192 polymorphism of paraox-onaseand coronary heart disease in type 2 diabetes. Lancet 1995:346:869-872.
10. Catto AJ, Carter AM, Barrett J, Stickland MH, Bamford JM, Davies JA, Grant PJ: Angiotensin converting enzyme insertion/deletion polymorphism and cerebrovascular disease. Stroke 1996:27:435-440.
11. Bamford J, Sandcrcock P, Dennis M, Brin J, Warlow C: Classification and natural history of clinically identifiable subtypes of cerebral infarction. Lancet 1991:337:1521-1526.
12. World Health Organisation: Diabetes mellitus. Report of a WHO study group. Technical Report. Geneva, World Health Organisation. 1985. No. 727.
13. WHO MONICA Project: WHO MONICA Project: Objectives and design. Int J Epidemiol 1989; 18:S29-S37.
14. Gustineich S, Manfioletti G, Del Sal G, Schneider C: A fast method for high-quality genomic DNA extraction from whole human blood. Biotechniques 1991:11:298-301.